To the Editor,
As is the case all over the world, we are faced with a very contagious virus outbreak: Coronavirus disease (COVID-19) pandemic [1]. In the pandemic conditions, unavoidably, specimens from the patients with COVID-19 or suspected ones have been sent to clinical chemistry laboratories.
Although there is limited information regarding the vitality and infectivity of COVID-19, the virus is thought to spread mainly from person-to-person via respiratory droplets, so respiratory specimens such as nasopharyngeal and oropharyngeal swabs, sputum, and/or endotracheal aspirate or bronchoalveolar lavage fluid carry a high viral load. However, we have to accept potentially infectious materials such as blood, urine, stool, etc. specimens of patients with confirmed COVID-19.
In addition, most of these specimens will be received from intensive care units where there is a high level of patient contact, and therefore the outer surface of these specimens might be contagious for COVID 19. Table 1 summarizes the key transmission findings.
Key findings in mode of transmission.
| Source | RNA detected | Live virus |
|---|---|---|
| Nasopharynx | Yes | Yes |
| Sputum | Yes | Yes |
| Saliva | Yes | Yes |
| Stool | Yes | Yes |
| Blood | Yes | No |
| Conjunctiva | Yes | Yes |
| Vertical | Yes | N/A |
| Semen/vaginal fluids | Yes | |
| Urine | Yes | Yes |
| Cats | Yes | Yes |
Eventually, all laboratory staff is at risk of contamination of the new coronavirus [1]. Therefore, as clinical chemistry specialists, we have to ensure both our safety and the safety of other laboratory personnel. This is also the ethical responsibility of all of us.
Previously, we have shortened and translated the “Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) interim guidance” published by the World Health Organization on laboratory biosafety related to COVID 19 and shared it with the medical laboratory community in Turkey [2].
However, we think that there is a necessity for an outline and a list of preventative measures compatible with the realities of our country.
Highlights of COVID-19 laboratory biosafety [3], [4]
Prohibit unauthorized entrance. Only laboratory personnel should be allowed to enter the laboratory working areas.
Get laboratory coats, wear gowns and/or uniforms, and do not go home with these coats. Wash your uniform at over 60 °C.
Do not put your uniform in the same place (hanger, locker) together with your other coats.
Do not enter break rooms or dining halls with your laboratory coats.
Use different hospital shoes, do not take them home.
Keep your nails short.
Wear personal protective equipment (gloves, masks, goggles/glasses/face shields, uniforms long enough to cover the knees, gowns) when working.
Implement different procedures for specimens of patients with COVID-19 and separate them from the others. Ensure the laboratory is informed about these specimens before they are sent to the laboratory.
Ensure that sample transport staff and laboratory employees working in units of specimen acceptance, processing, and centrifugation wear personnel protective equipment such as gowns, N95 masks, gloves, and surgical headgears, etc.
Ideally, ensure that the pneumatic system is not used for samples of patients with COVID-19. If this is not completely possible, assuming that the pneumatic system is used for patients with COVID-19 as well, take the following measures:
Ensure not to be sent the specimens of the patients with COVID-19 in the same canister with the specimens of other patients.
If possible, open the pneumatic system canister in class I or class II biosafety cabinet. (It should be ideally preferred a class II biosafety cabinet for this process).
Certainly wear gloves, mask (ideally N95), surgical cap, and goggles when opening the pneumatic system canister.
Open the canister cap as slowly as possible and keeping your face as far away as possible.
Take the following measures in centrifugation processes:
If possible, use a separate centrifuge device for samples of patients with COVID-19.
Always wear gloves, masks, and goggles during centrifugation processes. Centrifuge the samples by closing the caps of the centrifugal buckets.
Wait at least 15 min after the centrifugation process without opening the lid of the centrifuge device.
If any breakage, scattering, spillage occurs during the centrifugation process, clean the centrifuge rotor, buckets, and lids with 1/10 diluted bleach or 75% alcohol solution with taking into consideration protection measures being biosafety level 3, and discard the waste separately in the medical waste container.
If possible, it is recommended that caps of evacuated tubes or containers should be opened in class I or class II biosafety cabinet (ideally, a class II biosafety cabinet should be used). However, we know that most biochemistry laboratories do not have a biosafety cabinet. Therefore, it would be appropriate to take the following measures:
Keep your face as far away as possible when opening the caps of evacuated tubes or vacutainer or containers.
When opening the cap, use gauze bandage soaked with disinfected liquid and put on gloves, mask (ideally N95), surgical cap, and goggles during the process.
Specimens of COVID-19 positive or presumptive patients should be placed in separate tube racks. If possible, use a different analyzer for these specimens. Specimen container caps should be kept as closed as possible. After completing analyses, the caps of these specimens have to be closed immediately and be kept until the result validation by laboratory specialists or laboratory technicians. These specimens should not be mixed with the other specimens at the outlet of the analyzer or when the analysis is finished. Sample waste must be collected in separate labeled medical waste bins. If possible, the waste decontamination should be done for the samples by an autoclave. When this is not the case, waste should be thrown into different medical waste bins in the same way.
Instrument covers have to be kept closed during the analyzes.
Pay attention to hand washing. Wash your hands after removing gloves. Remove any jewelry (rings, wrist, watches, etc.) which could prevent handwashing efficacy.
Tie your long hair or use disposable surgical caps.
Avoid touching your face.
After work, wash your hands up to the elbow, for at least 20 s with soap and water.
Keep mobile electronic devices outside the laboratory environment. After work, these devices should be wiped with warm soapy water or disinfectant.
All laboratory counters, desks, furniture, and the outer surfaces of analyzers should be cleaned with bleach diluted in water at 1:100 (75% alcoholic solution can be used for this purpose, too).
Don’t eat or drink in the place where samples are analyzed.
In case of a spill, the contaminated area should be wiped with bleach (from outward to inward) and the contaminated material should be thrown into the medical waste bin.
Clean your eyeglasses daily with an alcoholic solution (75%).
When the work is completed, disinfect the working places (specimen reception units, analyses units) with a UVC lamp at least for an hour.
Table 2 shows the scope of the required biosafety levels.
The biosafety levels and application areas [5].
| Safety level | Protective equipment | Application |
|---|---|---|
| BSL-1 |
|
|
| BSL-2 |
|
|
| BSL-3 |
|
|
BSL, Biosafety level.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: The authors declare that they have no conflict of interests.
References
1. Zhang, Z, Liu, S, Xiang, M, Li, S, Zhao, D, Huang, C, et al. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions. Front Med 2020;14:229–31. https://doi.org/10.1007/s11684-020-0765-x.Search in Google Scholar PubMed PubMed Central
2. Laboratory biosafety guidance related to coronavirus disease (COVID-19) interim guidance—13 May 2020. [Internet]. https://www.who.int/publications-detail/laboratory-biosafety-guidance-related-to-coronavirus-disease-(covid-19) [Accessed May 2020].Search in Google Scholar
3. Hawkins, R. Preparing the biochemistry laboratory for the next outbreak: lessons from SARS in Singapore. Clin Biochem Rev 2005;26:59–64. 16450013.Search in Google Scholar
4. Handbook of COVID-19 prevention and treatment. https://gmcc.alibabadoctor.com/prevention-manual [Accessed May 2020].Search in Google Scholar
5. World Health Organisation. Laboratory biosafety manual third edition. https://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf?ua=1 [Accessed May 2020].Search in Google Scholar
© 2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Research Articles
- Development of new total RNA isolation method for tissues with rich phenolic compounds
- Myofibrillar degeneration with diphtheria toxin
- In vitro and in silico studies on AChE inhibitory effects of a series of donepezil-like arylidene indanones
- In vitro antioxidant, anti-inflammatory and anti-cancer activities of methanolic extract of Asparagus horridus grows in North Cyprus Kuzey Kıbrıs da yetişen Asparagus horridus metanolik ekstraktının in-vitro antioksidan, anti-enflamatuar ve anti-kanser aktivitesi
- Purification and characterization of glucose-6-phosphate dehydrogenase from Eisenia fetida and effects of some pesticides and metal ions
- Nephroprotective effects of eriocitrin via alleviation of oxidative stress and DNA damage against cisplatin-induced renal toxicity
- The impact of orally administered gadolinium orthovanadate GdVO4:Eu3+ nanoparticles on the state of phospholipid bilayer of erythrocytes
- An anxiolytic drug buspirone ameliorates hyperglycemia and endothelial dysfunction in type 2 diabetic rat model
- Effects of mesenchymal stem cell and amnion membrane transfer on prevention of pericardial adhesions
- How potential endocrine disruptor deltamethrin effects antioxidant enzyme levels and total antioxidant status on model organisms
- Antiproliferative effect of rosehip tea phenolics in prostate cancer cell lines
- Investigation of MMP-9 rs3918242 and TIMP-2 rs8179090 polymorphisms in renal cell carcinoma tissues
- Investigation of SR-BI gene rs4238001 and rs5888 polymorphisms prevalence and effects on Turkish patients with metabolic syndrome
- Assessment of the frequency and biochemical parameters of conjunctivitis in COVID-19 and other viral and bacterial conditions
- Short Communication
- Lack of hotspot mutations other than TP53 R249S in aflatoxin B1 associated hepatocellular carcinoma
- Letter to the Editors
- Cornuside, identified in Corni fructus, suppresses melanin biosynthesis in B16/F10 melanoma cells through tyrosinase inhibition
- The extract of male bee and beehive from Bombus terrestris has biological efficacies for promoting skin health
- COVID-19 laboratory biosafety guide
- Retraction note
Articles in the same Issue
- Frontmatter
- Research Articles
- Development of new total RNA isolation method for tissues with rich phenolic compounds
- Myofibrillar degeneration with diphtheria toxin
- In vitro and in silico studies on AChE inhibitory effects of a series of donepezil-like arylidene indanones
- In vitro antioxidant, anti-inflammatory and anti-cancer activities of methanolic extract of Asparagus horridus grows in North Cyprus Kuzey Kıbrıs da yetişen Asparagus horridus metanolik ekstraktının in-vitro antioksidan, anti-enflamatuar ve anti-kanser aktivitesi
- Purification and characterization of glucose-6-phosphate dehydrogenase from Eisenia fetida and effects of some pesticides and metal ions
- Nephroprotective effects of eriocitrin via alleviation of oxidative stress and DNA damage against cisplatin-induced renal toxicity
- The impact of orally administered gadolinium orthovanadate GdVO4:Eu3+ nanoparticles on the state of phospholipid bilayer of erythrocytes
- An anxiolytic drug buspirone ameliorates hyperglycemia and endothelial dysfunction in type 2 diabetic rat model
- Effects of mesenchymal stem cell and amnion membrane transfer on prevention of pericardial adhesions
- How potential endocrine disruptor deltamethrin effects antioxidant enzyme levels and total antioxidant status on model organisms
- Antiproliferative effect of rosehip tea phenolics in prostate cancer cell lines
- Investigation of MMP-9 rs3918242 and TIMP-2 rs8179090 polymorphisms in renal cell carcinoma tissues
- Investigation of SR-BI gene rs4238001 and rs5888 polymorphisms prevalence and effects on Turkish patients with metabolic syndrome
- Assessment of the frequency and biochemical parameters of conjunctivitis in COVID-19 and other viral and bacterial conditions
- Short Communication
- Lack of hotspot mutations other than TP53 R249S in aflatoxin B1 associated hepatocellular carcinoma
- Letter to the Editors
- Cornuside, identified in Corni fructus, suppresses melanin biosynthesis in B16/F10 melanoma cells through tyrosinase inhibition
- The extract of male bee and beehive from Bombus terrestris has biological efficacies for promoting skin health
- COVID-19 laboratory biosafety guide
- Retraction note